Please enable JavaScript to continue using this application.

Compare $STOK vs $ZYME | Chartloom

Compare

$STOK vs $ZYME

Stoke Therapeutics Inc · Zymeworks Inc

STOK

Stoke Therapeutics Inc

ZYME

Zymeworks Inc

Compare $STOK vs $ZYME

Comparing Stoke Therapeutics Inc and Zymeworks Inc

STOKStoke Therapeutics Inc

ZYMEZymeworks Inc

STOKStoke Therapeutics Inc

Market cap

$1.54B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

47.27x

Rev growth (TTM)

-86.2%

YTD performance

-19.9%

52W performance

-18.9%

FCF yield

-11.7%

ZYMEZymeworks Inc

Market cap

$1.85B

P/E (TTM)

—

Forward P/E (NTM)

8.20x

Forward P/S (NTM)

3.91x

Rev growth (TTM)

-69.8%

YTD performance

-3.1%

52W performance

54.6%

FCF yield

-6.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

STOK

ZYME

Detailed metrics comparison

STOK

Stoke Therapeutics Inc

ZYME

Zymeworks Inc

Market Cap

STOK$1.54B

ZYME$1.85B

Enterprise Value

STOK$1.43B

ZYME$1.92B

Price

STOK$24.74

ZYME$25.79

P/E Ratio

STOKN/A

ZYMEN/A

P/S Ratio

STOK55.85x

ZYME49.73x

EV/Sales

STOK51.86x

ZYME51.70x

EV/EBITDA

STOK53.69x

ZYME9.18x

P/B Ratio

STOK4.78x

ZYME23.27x

P/FCF Ratio

STOKN/A

ZYMEN/A

EV/FCF

STOK-7.92x

ZYME-15.91x

PEG Ratio

STOKN/A

ZYMEN/A

Forward P/E (NTM)

STOKN/A

ZYME8.20x

Forward P/S (NTM)

STOK47.27x

ZYME3.91x

Revenue (TTM)

STOK$28M

ZYME$37M

Revenue Growth (YoY)

STOK-86.2%

ZYME-69.8%

Forward Rev Growth

STOK62.9%

ZYME-15.2%

Gross Margin (TTM)

STOK0.0%

ZYME0.0%

Operating Margin (TTM)

STOK0.0%

ZYME0.0%

EBITDA Margin (TTM)

STOK-803.4%

ZYME-405.8%

Net Margin (TTM)

STOK-753.6%

ZYME-404.0%

FCF Margin (TTM)

STOK-654.9%

ZYME-325.1%

Net Income (TTM)

STOK$-208M

ZYME$-150M

FCF (TTM)

STOK$-181M

ZYME$-121M

EPS (TTM)

STOK-$3.15

ZYME-$2.05

ROE (TTM)

STOK-5936.0%

ZYME-7207.0%

ROA (TTM)

STOK-5146.0%

ZYME-3706.0%

ROIC (TTM)

STOK-5936.0%

ZYME-4505.0%

Cash

STOK$110M

ZYME$179M

Debt

STOK$0

ZYME$253M

Net Cash/Debt

STOK$110M

ZYME$-73M

Current Ratio (TTM)

STOK7.69x

ZYME6.32x

Quick Ratio (TTM)

STOK7.34x

ZYME5.86x

Debt/Equity (TTM)

STOK0.00x

ZYME3.14x

Debt/Assets (TTM)

STOK0.0%

ZYME0.0%

Interest Coverage (TTM)

STOKN/A

ZYMEN/A

Net Debt/EBITDA (TTM)

STOK0.00x

ZYME0.00x

Beta

STOK1.36

ZYME1.32

52W Performance

STOK-18.9%

ZYME54.6%

YTD Performance

STOK-19.9%

ZYME-3.1%

% from 52W High

STOK-38.5%

ZYME-17.7%

% from 52W Low

STOK21.8%

ZYME61.2%

Asset Turnover (TTM)

STOK0.07x

ZYME0.09x

FCF Yield (TTM)

STOK-11.7%

ZYME-6.5%

Earnings Yield (TTM)

STOK-13.5%

ZYME-8.1%

Dividend Yield (TTM)

STOKN/A

ZYMEN/A

Rule of 40

STOK-741.1

ZYME-394.8

EV/GP/RG

STOKN/A

ZYMEN/A

Ticker research

View STOK research View ZYME research

Metric	STOK Stoke Therapeutics Inc	ZYME Zymeworks Inc
Market & Valuation
Market Cap	$1.54B	$1.85B
Enterprise Value	$1.43B	$1.92B
Price	$24.74	$25.79
P/E Ratio	N/A	N/A
P/S Ratio	55.85x	49.73x
EV/Sales	51.86x	51.70x
EV/EBITDA	53.69x	9.18x
P/B Ratio	4.78x	23.27x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.92x	-15.91x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	8.20x
Forward P/S (NTM)	47.27x	3.91x
Revenue & Growth
Revenue (TTM)	$28M	$37M
Revenue Growth (YoY)	-86.2%	-69.8%
Forward Rev Growth	62.9%	-15.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-803.4%	-405.8%
Net Margin (TTM)	-753.6%	-404.0%
FCF Margin (TTM)	-654.9%	-325.1%
Net Income (TTM)	$-208M	$-150M
FCF (TTM)	$-181M	$-121M
EPS (TTM)	-$3.15	-$2.05
ROE (TTM)	-5936.0%	-7207.0%
ROA (TTM)	-5146.0%	-3706.0%
ROIC (TTM)	-5936.0%	-4505.0%
Financial Health
Cash	$110M	$179M
Debt	$0	$253M
Net Cash/Debt	$110M	$-73M
Current Ratio (TTM)	7.69x	6.32x
Quick Ratio (TTM)	7.34x	5.86x
Debt/Equity (TTM)	0.00x	3.14x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.36	1.32
52W Performance	-18.9%	54.6%
YTD Performance	-19.9%	-3.1%
% from 52W High	-38.5%	-17.7%
% from 52W Low	21.8%	61.2%
Efficiency & Yields
Asset Turnover (TTM)	0.07x	0.09x
FCF Yield (TTM)	-11.7%	-6.5%
Earnings Yield (TTM)	-13.5%	-8.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-741.1	-394.8
EV/GP/RG	N/A	N/A
Ticker research	View STOK research	View ZYME research

Valuation

P/S Ratio

ZYME

49.73x

STOK

55.85x

EV/FCF

ZYME

-15.91x

STOK

-7.92x

Growth & revenue

Revenue Growth TTM

ZYME

-69.8%

STOK

-86.2%

Forward Revenue Growth

STOK

62.9%

ZYME

-15.2%

Profitability & performance

Gross Margin

STOK

0.0%

ZYME

0.0%

ROE

STOK

-5936.0%

ZYME

-7207.0%

FCF Yield %

ZYME

-6.5%

STOK

-11.7%

52-Week Performance

ZYME

54.6%

STOK

-18.9%

Detailed metrics comparison

STOK

Stoke Therapeutics Inc

ZYME

Zymeworks Inc

Market Cap

STOK$1.54B

ZYME$1.85B

Enterprise Value

STOK$1.43B

ZYME$1.92B

Price

STOK$24.74

ZYME$25.79

P/E Ratio

STOKN/A

ZYMEN/A

P/S Ratio

STOK55.85x

ZYME49.73x

EV/Sales

STOK51.86x

ZYME51.70x

EV/EBITDA

STOK53.69x

ZYME9.18x

P/B Ratio

STOK4.78x

ZYME23.27x

P/FCF Ratio

STOKN/A

ZYMEN/A

EV/FCF

STOK-7.92x

ZYME-15.91x

PEG Ratio

STOKN/A

ZYMEN/A

Forward P/E (NTM)

STOKN/A

ZYME8.20x

Forward P/S (NTM)

STOK47.27x

ZYME3.91x

Revenue (TTM)

STOK$28M

ZYME$37M

Revenue Growth (YoY)

STOK-86.2%

ZYME-69.8%

Forward Rev Growth

STOK62.9%

ZYME-15.2%

Gross Margin (TTM)

STOK0.0%

ZYME0.0%

Operating Margin (TTM)

STOK0.0%

ZYME0.0%

EBITDA Margin (TTM)

STOK-803.4%

ZYME-405.8%

Net Margin (TTM)

STOK-753.6%

ZYME-404.0%

FCF Margin (TTM)

STOK-654.9%

ZYME-325.1%

Net Income (TTM)

STOK$-208M

ZYME$-150M

FCF (TTM)

STOK$-181M

ZYME$-121M

EPS (TTM)

STOK-$3.15

ZYME-$2.05

ROE (TTM)

STOK-5936.0%

ZYME-7207.0%

ROA (TTM)

STOK-5146.0%

ZYME-3706.0%

ROIC (TTM)

STOK-5936.0%

ZYME-4505.0%

Cash

STOK$110M

ZYME$179M

Debt

STOK$0

ZYME$253M

Net Cash/Debt

STOK$110M

ZYME$-73M

Current Ratio (TTM)

STOK7.69x

ZYME6.32x

Quick Ratio (TTM)

STOK7.34x

ZYME5.86x

Debt/Equity (TTM)

STOK0.00x

ZYME3.14x

Debt/Assets (TTM)

STOK0.0%

ZYME0.0%

Interest Coverage (TTM)

STOKN/A

ZYMEN/A

Net Debt/EBITDA (TTM)

STOK0.00x

ZYME0.00x

Beta

STOK1.36

ZYME1.32

52W Performance

STOK-18.9%

ZYME54.6%

YTD Performance

STOK-19.9%

ZYME-3.1%

% from 52W High

STOK-38.5%

ZYME-17.7%

% from 52W Low

STOK21.8%

ZYME61.2%

Asset Turnover (TTM)

STOK0.07x

ZYME0.09x

FCF Yield (TTM)

STOK-11.7%

ZYME-6.5%

Earnings Yield (TTM)

STOK-13.5%

ZYME-8.1%

Dividend Yield (TTM)

STOKN/A

ZYMEN/A

Rule of 40

STOK-741.1

ZYME-394.8

EV/GP/RG

STOKN/A

ZYMEN/A

Ticker research

View STOK research View ZYME research

Metric	STOK Stoke Therapeutics Inc	ZYME Zymeworks Inc
Market & Valuation
Market Cap	$1.54B	$1.85B
Enterprise Value	$1.43B	$1.92B
Price	$24.74	$25.79
P/E Ratio	N/A	N/A
P/S Ratio	55.85x	49.73x
EV/Sales	51.86x	51.70x
EV/EBITDA	53.69x	9.18x
P/B Ratio	4.78x	23.27x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.92x	-15.91x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	8.20x
Forward P/S (NTM)	47.27x	3.91x
Revenue & Growth
Revenue (TTM)	$28M	$37M
Revenue Growth (YoY)	-86.2%	-69.8%
Forward Rev Growth	62.9%	-15.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-803.4%	-405.8%
Net Margin (TTM)	-753.6%	-404.0%
FCF Margin (TTM)	-654.9%	-325.1%
Net Income (TTM)	$-208M	$-150M
FCF (TTM)	$-181M	$-121M
EPS (TTM)	-$3.15	-$2.05
ROE (TTM)	-5936.0%	-7207.0%
ROA (TTM)	-5146.0%	-3706.0%
ROIC (TTM)	-5936.0%	-4505.0%
Financial Health
Cash	$110M	$179M
Debt	$0	$253M
Net Cash/Debt	$110M	$-73M
Current Ratio (TTM)	7.69x	6.32x
Quick Ratio (TTM)	7.34x	5.86x
Debt/Equity (TTM)	0.00x	3.14x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.36	1.32
52W Performance	-18.9%	54.6%
YTD Performance	-19.9%	-3.1%
% from 52W High	-38.5%	-17.7%
% from 52W Low	21.8%	61.2%
Efficiency & Yields
Asset Turnover (TTM)	0.07x	0.09x
FCF Yield (TTM)	-11.7%	-6.5%
Earnings Yield (TTM)	-13.5%	-8.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-741.1	-394.8
EV/GP/RG	N/A	N/A
Ticker research	View STOK research	View ZYME research